GlassScriptPhysician profile
John A Sarkaria
NPI 1245250695
$603.48
in general payments reported to CMS, 2019-2025
12 companies · $80.29 in 2025
The $80.29 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.61 · 2020: $216 · 2021: $57.69 · 2022: $19.71 · 2023: $49.69 · 2024: $120 · 2025: $80.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $249.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $222.00 | 2020-2021 | |
| Lilly USA, LLC | $74.53 | 2021-2025 | Mounjaro |
| Exact Sciences Corporation | $66.63 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $57.73 | 2021-2024 | |
| Novo Nordisk INC | $43.33 | 2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $31.08 | 2019 | |
| Abbott Laboratories | $28.16 | 2024 | Freestyle Libre 3 |
| Edwards Lifesciences Corporation | $19.13 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Janssen Pharmaceuticals, INC | $17.52 | 2019 | |
| Pfizer INC. | $16.75 | 2020 | |
| Acella Pharmaceuticals, LLC | $14.61 | 2024 | NP Thyroid 60 |
| Merck Sharp & Dohme LLC | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sarkaria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.